Congress Main Topics
-
Special session for patients’ advocacy group
-
Advances in disease biology
-
Immunotherapy: from the bench to the bedside
-
Treatment guidelines for the young patients
-
Outcome prediction
-
Choice of therapy for non-transplant eligible patients
-
Guidelines in specific clinical situations
-
Treatment of relapse
-
Expert advice on How I manage myeloma?
-
Options for refractory myeloma
-
Ongoing clinical trials and future trials
-
Are we ready to personalize therapy today?
-
CAR T cells in myeloma
-
Smoldering myeloma should be treated very early
-
Cost of therapy
-
Practical guidelines for the practicing physician
-
The future of myeloma therapy
-
AL amyloidosis: update on biology and therapy
-
Waldenstrom macroglobulinemia: update on biology and therapy